MiR-204 enhances mitochondrial apoptosis in doxorubicin-treated prostate cancer cells by targeting SIRT1/p53 pathwayShu Yan(Tongde Hospital of Zhejiang Province), Jing Chen(Tongde Hospital of Zhejiang Province)OncotargetOctober 23, 201710.18632/oncotarget.21960Cited by 39SaveCiteExport RISWatch citationsRelated PapersQuercetin reverses the doxorubicin resistance of prostate cancer cells by downregulating the expression of c‑met|Oncology Letters|2017|45